By Dorothy Atkins ( May 6, 2020, 9:34 PM EDT) -- A California federal judge said Wednesday he's inclined to grant Otsuka Pharmaceutical Co. Ltd.'s bid for a win against a consumer's suit claiming the drugmaker failed to warn her about the risks of taking the antipsychotic drug Abilify, pointing to the lack of incident-rate data backing the claim....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.